# RESULT.default=You do not have the two genetic variants we tested in the LRRK2 and GBA genes. Your risk for Parkinson's disease also depends on other factors, including environment and genetic varaints not covered by this test.						# REFERENCE.default=Alcalay RN, Dinur T, Quinn T, et al. Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes. JAMA Neurol. 2014;71(6):752-7.|Asselta R, Rimoldi V, Siri C, et al. Glucocerebrosidase mutations in primary parkinsonism. Parkinsonism Relat Disord. 2014;20(11):1215-20.|Chen H, Zhang SM, Schwarzschild MA, Hernan MA, Ascherio A. Physical activity and the risk of Parkinson disease. Neurology. 2005;64(4):664-9.|Clark LN, Wang Y, Karlins E, et al. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology. 2006;67(10):1786-91.|Crane PK, Gibbons LE, Dams-O'Connor K, et al. Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings. JAMA Neurol. 2016;73(9):1062-1069.|Farlow J er al. (1993). Parkinson Disease Overview In: Pagon RA er al., editors. GeneReviews.						# Action.default=Environment and other factors can also influence the chances of developing Parkinson's disease. Consult with a healthcare professional before making any major lifestyle changes.						# Action.description=Suggested actions to take based on your genetic result.						FEATURE	FEATURE TYPE	REGION	STATE	RESULT	REFERENCE	Actionrs34637584;rs76763715	variant;variant	12:40340400-40340400;1:155235843-155235843	G|G;T|T	You do not have the two genetic variants we tested in the LRRK2 and GBA genes. Your risk for Parkinson's disease also depends on other factors, including environment and genetic varaints not covered by this test.	Alcalay RN, Dinur T, Quinn T, et al. Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes. JAMA Neurol. 2014;71(6):752-7.|Asselta R, Rimoldi V, Siri C, et al. Glucocerebrosidase mutations in primary parkinsonism. Parkinsonism Relat Disord. 2014;20(11):1215-20.|Chen H, Zhang SM, Schwarzschild MA, Hernan MA, Ascherio A. Physical activity and the risk of Parkinson disease. Neurology. 2005;64(4):664-9.|Clark LN, Wang Y, Karlins E, et al. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology. 2006;67(10):1786-91.|Crane PK, Gibbons LE, Dams-O'Connor K, et al. Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings. JAMA Neurol. 2016;73(9):1062-1069.|Farlow J er al. (1993). Parkinson Disease Overview In: Pagon RA er al., editors. GeneReviews.	Environment and other factors can also influence the chances of developing Parkinson's disease. Consult with a healthcare professional before making any major lifestyle changes.rs34637584;rs76763715	variant;variant	12:40340400-40340400;1:155235843-155235843	G|A;T|T	You have 1 variant in the LRRK2 gene out of the two genetic variants we tested. People with this variant have an increased risk of developing Parkinson's disease.	Alcalay RN, Dinur T, Quinn T, et al. Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes. JAMA Neurol. 2014;71(6):752-7.|Asselta R, Rimoldi V, Siri C, et al. Glucocerebrosidase mutations in primary parkinsonism. Parkinsonism Relat Disord. 2014;20(11):1215-20.|Chen H, Zhang SM, Schwarzschild MA, Hernan MA, Ascherio A. Physical activity and the risk of Parkinson disease. Neurology. 2005;64(4):664-9.|Clark LN, Wang Y, Karlins E, et al. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology. 2006;67(10):1786-91.|Crane PK, Gibbons LE, Dams-O'Connor K, et al. Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings. JAMA Neurol. 2016;73(9):1062-1069.|Farlow J er al. (1993). Parkinson Disease Overview In: Pagon RA er al., editors. GeneReviews.	Consider discussing your risk with a healthcare professional, especially if you have a family history or other fisk factors for this condition.rs34637584;rs76763715	variant;variant	12:40340400-40340400;1:155235843-155235843	G|G;T|C	You have 1 variant in the GBA gene out of the two genetic variants we tested. People with this variant have a slightly increased risk of developing Parkinson's disease.	Alcalay RN, Dinur T, Quinn T, et al. Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes. JAMA Neurol. 2014;71(6):752-7.|Asselta R, Rimoldi V, Siri C, et al. Glucocerebrosidase mutations in primary parkinsonism. Parkinsonism Relat Disord. 2014;20(11):1215-20.|Chen H, Zhang SM, Schwarzschild MA, Hernan MA, Ascherio A. Physical activity and the risk of Parkinson disease. Neurology. 2005;64(4):664-9.|Clark LN, Wang Y, Karlins E, et al. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology. 2006;67(10):1786-91.|Crane PK, Gibbons LE, Dams-O'Connor K, et al. Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings. JAMA Neurol. 2016;73(9):1062-1069.|Farlow J er al. (1993). Parkinson Disease Overview In: Pagon RA er al., editors. GeneReviews.	Consider discussing your risk with a healthcare professional, especially if you have a family history or other fisk factors for this condition.rs34637584;rs76763715	variant;variant	12:40340400-40340400;1:155235843-155235843	G|A;T|C	You have both of the genetic variants we tested, 1 variant in the LRRK2 gene and 1 variant in the GBA gene. People with these variants have an increased risk of developing Parkinson's disease.	Alcalay RN, Dinur T, Quinn T, et al. Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes. JAMA Neurol. 2014;71(6):752-7.|Asselta R, Rimoldi V, Siri C, et al. Glucocerebrosidase mutations in primary parkinsonism. Parkinsonism Relat Disord. 2014;20(11):1215-20.|Chen H, Zhang SM, Schwarzschild MA, Hernan MA, Ascherio A. Physical activity and the risk of Parkinson disease. Neurology. 2005;64(4):664-9.|Clark LN, Wang Y, Karlins E, et al. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology. 2006;67(10):1786-91.|Crane PK, Gibbons LE, Dams-O'Connor K, et al. Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings. JAMA Neurol. 2016;73(9):1062-1069.|Farlow J er al. (1993). Parkinson Disease Overview In: Pagon RA er al., editors. GeneReviews.	Consider discussing your risk with a healthcare professional, especially if you have a family history or other fisk factors for this condition.rs34637584;rs76763715	variant;variant	12:40340400-40340400;1:155235843-155235843	A|A;T|T	You have 2 copies of a genetic variant we tested in the LRRK2 gene. People with this result have an increased risk of developing Parkinson's disease.	Alcalay RN, Dinur T, Quinn T, et al. Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes. JAMA Neurol. 2014;71(6):752-7.|Asselta R, Rimoldi V, Siri C, et al. Glucocerebrosidase mutations in primary parkinsonism. Parkinsonism Relat Disord. 2014;20(11):1215-20.|Chen H, Zhang SM, Schwarzschild MA, Hernan MA, Ascherio A. Physical activity and the risk of Parkinson disease. Neurology. 2005;64(4):664-9.|Clark LN, Wang Y, Karlins E, et al. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology. 2006;67(10):1786-91.|Crane PK, Gibbons LE, Dams-O'Connor K, et al. Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings. JAMA Neurol. 2016;73(9):1062-1069.|Farlow J er al. (1993). Parkinson Disease Overview In: Pagon RA er al., editors. GeneReviews.	Consider discussing your risk with a healthcare professional, especially if you have a family history or other fisk factors for this condition.rs34637584;rs76763715	variant;variant	12:40340400-40340400;1:155235843-155235843	G|G;C|C	You have 2 copies of a genetic variant we tested in the GBA gene. People with this result have a slightly increased risk of developing Parkinson's disease.	Alcalay RN, Dinur T, Quinn T, et al. Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes. JAMA Neurol. 2014;71(6):752-7.|Asselta R, Rimoldi V, Siri C, et al. Glucocerebrosidase mutations in primary parkinsonism. Parkinsonism Relat Disord. 2014;20(11):1215-20.|Chen H, Zhang SM, Schwarzschild MA, Hernan MA, Ascherio A. Physical activity and the risk of Parkinson disease. Neurology. 2005;64(4):664-9.|Clark LN, Wang Y, Karlins E, et al. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology. 2006;67(10):1786-91.|Crane PK, Gibbons LE, Dams-O'Connor K, et al. Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings. JAMA Neurol. 2016;73(9):1062-1069.|Farlow J er al. (1993). Parkinson Disease Overview In: Pagon RA er al., editors. GeneReviews.	Consider discussing your risk with a healthcare professional, especially if you have a family history or other fisk factors for this condition.